Sennosides

💊 Sennosides (Senna Extract)

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Compliance Strategy
📌 I. Product Definition & Classification: Do You Truly Understand "Sennosides"?

Sennosides are the active anthraquinone glycosides derived from the leaves and pods of the Senna alexandrina plant (also known as Senna alexandrina or Cassia senna). In international trade, they are primarily classified based on their form and intended use:

1. Botanical Raw Material (Herbal Medicine/Pharmaceutical Raw Material):
- Dried leaves, pods, or powder of the Senna plant.
- Used as raw material for further processing or traditional herbal preparations.
- HS Code Trend: Typically falls under Chapter 12 (Oil seeds, fruit) or Chapter 30 (Pharmaceuticals), depending on whether it is "raw" or "processed for therapeutic use."

2. Isolated/Extracted Sennosides (Active Pharmaceutical Ingredient - API):
- Purified sennosides (e.g., Sennosides A, B, C, D) extracted via chemical/physical processes.
- Used in laxative medications, dietary supplements, and clinical treatments.
- HS Code Trend: Classified under Chapter 30 (Pharmaceutical Products), specifically as "Preparations for therapeutic or prophylactic uses."

⚠️ Key Distinction Point:
- If it is raw herbal material (leaves/pods/powder without purification) → Often 1211.90 or 0909.60 (depending on region).
- If it is purified extract/API for pharmaceutical/dietary supplement use → 3004.90 or 1302.19.
- Regulatory Impact: API classification triggers stricter FDA/EMA compliance (GMP, DMF filing).

📦 II. HS Code Classification Details (2026 Latest Tariff Authority Match)

🔍 Critical Reminder:
- USA/EU: Pure Sennosides API is almost always classified under 3004.90 (Pharmaceuticals).
- Raw Material: If imported for extraction, some countries allow 1211.90 (lower duty), but customs may reclassify if purity >90%.
- Dietary Supplements: If marketed as "Herbal Laxative" with minimal processing, may fall under 1302.19 or 2106.90 (Food Preparations), but this is risky if claims are therapeutic.

💰 III. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)

✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Date: 2025–2026 (Subject to USITC/Trade War updates)

🎯 1. 1211.90.96 —— Raw Senna Leaves/Pods (Botanical Material)

📌 Explanation:
- Raw herbal materials often enjoy 0% base duty.
- However, if classified under "Herbal Extracts" rather than "Plants," surtaxes may apply.
- De Minimis ($800) is a major advantage for small B2C shipments of herbal powders.

🎯 2. 3004.90.90 —— Purified Sennosides API / Laxative Preparations

📌 Critical Warning:
- Pharmaceutical classification (3004) is highly regulated.
- No De Minimis exemption for APIs or prescription-grade sennosides in many cases.
- Must comply with FDA 21 CFR Part 211 (GMP) for APIs.
- If misclassified as "Herbal Supplement" (2106.90) but contains >90% pure sennosides, customs/FDA may penalize for misdeclaration.

🎯 3. 1302.19.50 —— Senna Extract (Semi-Purified)

📌 Note:
- This classification is a gray area. If purity is >50%, customs may push to 3004.
- Suitable for "Natural Laxative Tea" or "Herbal Supplement" marketing.

🛠️ IV. Customs Clearance Practical Advice (Real-World Pitfall Avoidance)

✅ 1. Required Documentation Checklist

✅ 2. Declaration Tips (Key Mantra)

🔥 "Raw is 1211, Pure is 3004, Extract is 1302, Misclassify and Pay!"

✅ 3. Special Cases

🌍 V. Global Market Comparison (2026 Latest)

📌 Conclusion:
- USA has the highest regulatory barrier (FDA + Trade War taxes).
- Raw Senna is easier to clear globally under Chapter 12.
- Pure Sennosides API is universally classified under Chapter 30, triggering pharmaceutical regulations.

📌 VI. Common Mistakes & Pitfalls (Blood & Tears Lessons)

❌ Mistake 1: Declaring "Purified Sennosides" as "Herbal Tea" to avoid FDA.
👉 Consequence: FDA rejects shipment, demands re-export or destruction. Fine up to $10,000+.

❌ Mistake 2: Using "Senna Extract" without specifying purity.
👉 Consequence: Customs inspects, finds 90% purity, reclassifies to 3004, imposes back duties + penalties.

❌ Mistake 3: Ignoring Section 301/IEEPA surtaxes for China-origin API.
👉 Consequence: Unexpected 35% total duty on top of base rate. Profit margin erased.

❌ Mistake 4: Missing FDA Prior Notice for food/drug ingredients.
👉 Consequence: Cargo held at port, $2,500+ per day storage fees.

✅ Correct Approach:

"Sennosides, Purified, >90%, For Pharmaceutical Use, GMP Certified, China Origin"
→ Classify as 3004.90.90, file FDA Prior Notice, pay applicable surtaxes.

🎯 VII. Conclusion: Precise Classification Saves Money & Time

🎯 Remember the Mantra:

🔹 "Raw Leaves = 1211, Pure API = 3004, Extract = 1302, Mislabel = Pain!"
🔹 "FDA Prior Notice is Mandatory, De Minimis Doesn’t Apply to Drugs!"
🔹 "China-Origin API = 35% Duty, Non-China Origin = 0% Surtax!"

📌 Pro Tip:
If you are importing Sennosides for dietary supplements, ensure your label complies with DSHEA (Dietary Supplement Health and Education Act) in the US. If you claim "treats constipation," it’s a drug, not a supplement, and requires NDA (New Drug Application) or OTC Monograph compliance.

📣 Immediate Action:

📞 Consult a Customs Broker + Provide COA & Label Artwork + File FDA Prior Notice
🚀 Ensure Smooth Clearance, Avoid Penalties, Maximize Profit!

✨ Professional Customs Clearance Starts with Accurate Classification!
💼 Your Compliance is Your Competitive Advantage!